Welcure Drugs & Pharmaceuticals Ltd. benchmarking: Performance to industry peers

Financial

	Welcure Drugs&Pharma	Supha Pharmachem	ABM International
Operational Metrics
Financials
5 yr Average ROE	45.81 %	38.8 %	9.98 %
5yr average Equity Multiplier	-0.38	60.3	1.82
5yr Average Asset Turnover Ratio	0.25	1.25	3.31
5yr Avg Net Profit Margin	-80.17 %	0.65 %	-0.84 %
Price to Book	0.28	0.35	2.84
P/E	1.05	17.4	0.0
5yr Avg Cash Conversion Cycle	2364.01 Days	478.33 Days	25.53 Days
Inventory Days	20.66 Days	78.27 Days	34.05 Days
Days Receivable	1232.42 Days	694.98 Days	19.16 Days
Days Payable	0.0	156.76 Days	31.7 Days
5yr Average Interest Coverage Ratio	-2.67	9.58	16.63
5yr Avg ROCE	-7.19 %	66.83 %	-8.47 %
5yr Avg Operating Profit Margin	-81.01 %	0.73 %	-1.72 %
5 yr average Debt to Equity	-0.35	6.84	0.35
5yr CAGR Net Profit	-2.01 %	14.55 %	n/a
5yr Average Return on Assets	-1.33 %	0.69 %	0.82 %
Shareholdings
Promoter Holding	0.0	1.13 %	74.7 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	0.0	0.02 %	0.0
Change in Mutual Fund Holding (3 Yrs)	0.0	0.0	0.0